Copyright
©The Author(s) 2024.
World J Hepatol. May 27, 2024; 16(5): 791-799
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.791
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.791
Table 1 Annual number of patients with Wilson disease
Calendar year | Patients with WD in the database |
20161 | 1887 |
2017 | 2239 |
2018 | 2253 |
2019 | 2356 |
2020 | 2220 |
2021 | 2277 |
Table 2 Clinical manifestations during follow-up
Type of manifestation | All patients | Patients with documented treatment | Patients with no documented treatment | P value by χ² test |
n = 5376 | n = 885 | n = 4491 | ||
Hepatic manifestations | 1796 (33.4) | 389 (44.0) | 1288 (28.7) | < 0.001 |
Neurological manifestations | 1935 (36.0) | 302 (34.1) | 1577 (35.1) | 0.572 |
Psychiatric manifestations | 2433 (45.3) | 383 (43.3) | 1977 (44.0) | 0.683 |
At least one of the above | 3829 (71.2) | 649 (73.3) | 3060 (68.1) | 0.002 |
Table 3 Hospitalisations
Parameter | All patients | Patients with documented treatment | Patients with no documented treatment | P value by χ² test | |
n = 5376 | n = 885 | n = 4491 | |||
Day hospitalisations, n (%) | 4991 (92.8) | 865 (97.7) | 4126 (91.9) | < 0.0001 | |
Overnight hospitalisations, n (%) | 1564 (29.1) | 295 (33.3) | 1269 (28.3) | 0.0023 | |
Length of stay1, median (IQR) | 6 (2–16) | 6 (2–17) | 6 (2–17) | NA | |
Liver transplantation, n (%) | 121 (2.3) | 23 (2.6) | 98 (2.2) | NA |
Table 4 Mortality
Insurees with WD | All insurees | |||||
Year | Total n | Deaths | Mortality rate, % | Total n | Deaths | Mortality rate, % |
20161 | 1887 | 27 | 1.43 | 203060882 | 1991215 | 0.98 |
2017 | 2239 | 51 | 2.28 | 223313801 | 2341297 | 1.05 |
2018 | 2253 | 58 | 2.57 | 223828962 | 2420297 | 1.08 |
2019 | 2356 | 61 | 2.59 | 219088011 | 2390049 | 1.09 |
2020 | 2220 | 63 | 2.84 | 215457629 | 2461627 | 1.14 |
20212 | 2277 | 13 | 0.57 | 239164264 | 205313 | 0.09 |
Total | 5376 | 273 | 5.08 | 431039425 | 11809798 | 2.74 |
- Citation: Daniel-Robin T, Kumar P, Benichou B, Combal JP. Characteristics of patients with Wilson disease in the United States: An insurance claims database study. World J Hepatol 2024; 16(5): 791-799
- URL: https://www.wjgnet.com/1948-5182/full/v16/i5/791.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i5.791